🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
March 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — March 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(2002)
All (2002)
Buys (178)
Sells (1824)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
TENET HEALTHCARE CORP
(THC)
Arnst Thomas W
— EVP, Chief Admin. Officer & GC
Mar 9, 2026
Sale
Shares
3,286
Price
$239.46
Total Value
$786.87K
Shares Held After
12
% of Holdings
99.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TENET HEALTHCARE CORP
(THC)
Arnst Thomas W
— EVP, Chief Admin. Officer & GC
Mar 9, 2026
Sale
Shares
4,714
Price
$238.42
Total Value
$1.12M
Shares Held After
3,298
% of Holdings
58.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
RUBINSTEIN JULIE
— President and COO
Mar 9, 2026
Sale
Shares
30,941
Price
$14.79
Total Value
$457.62K
Shares Held After
647,809
% of Holdings
4.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
KalVista Pharmaceuticals, Inc.
(KALV)
Palleiko Benjamin L
— Director
Mar 9, 2026
Sale
Shares
6,693
Price
$16.08
Total Value
$107.63K
Shares Held After
451,815
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SERA PROGNOSTICS, INC.
(SERA)
Boniface John J.
— Chief Scientific Officer
Mar 9, 2026
Sale
Shares
3,038
Price
$1.96
Total Value
$5.95K
Shares Held After
147,359
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SERA PROGNOSTICS, INC.
(SERA)
Aerts Austin
— Chief Financial Officer
Mar 9, 2026
Sale
Shares
674
Price
$1.96
Total Value
$1.32K
Shares Held After
271,540
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SERA PROGNOSTICS, INC.
(SERA)
Jackson Benjamin
— General Counsel
Mar 9, 2026
Sale
Shares
3,119
Price
$1.96
Total Value
$6.11K
Shares Held After
115,747
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SERA PROGNOSTICS, INC.
(SERA)
Harrison Robert Gardner
— Chief Information Officer
Mar 9, 2026
Sale
Shares
3,360
Price
$1.96
Total Value
$6.59K
Shares Held After
77,428
% of Holdings
4.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SERA PROGNOSTICS, INC.
(SERA)
Kearney Paul
— Chief Data Officer
Mar 9, 2026
Sale
Shares
2,026
Price
$1.96
Total Value
$3.97K
Shares Held After
165,357
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alphatec Holdings, Inc.
(ATEC)
Hunsaker Craig E
— EVP, PEOPLE & CULTURE
Mar 9, 2026
Sale
Shares
82,765
Price
$12.45
Total Value
$1.03M
Shares Held After
1,726,209
% of Holdings
4.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
Blum Robert I
— Director
Mar 9, 2026
Sale
Shares
7,931
Price
$60.72
Total Value
$481.57K
Shares Held After
391,673
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
Malik Fady Ibraham
— EVP Research & Development
Mar 9, 2026
Sale
Shares
2,907
Price
$60.72
Total Value
$176.51K
Shares Held After
138,629
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
Callos Andrew
— EVP, Chief Commercial Officer
Mar 9, 2026
Sale
Shares
2,582
Price
$60.72
Total Value
$156.78K
Shares Held After
47,858
% of Holdings
5.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ANI PHARMACEUTICALS INC
(ANIP)
Davis Krista
— SVP, CHIEF HR OFFICER
Mar 9, 2026
Sale
Shares
5,087
Price
$74.13
Total Value
$377.10K
Shares Held After
51,946
% of Holdings
8.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zai Lab Ltd
(ZLAB)
Du Ying
— Director
Mar 9, 2026
Sale
Shares
50,000
Price
$19.03
Total Value
$951.47K
Shares Held After
964,161
% of Holdings
4.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ANI PHARMACEUTICALS INC
(ANIP)
Mutz Christopher
— HEAD OF RARE DISEASE
Mar 9, 2026
Sale
Shares
3,602
Price
$74.18
Total Value
$267.20K
Shares Held After
94,471
% of Holdings
3.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Privia Health Group, Inc.
(PRVA)
Mountcastle David
— EVP & Chief Financial Officer
Mar 9, 2026
Sale
Shares
5,829
Price
$22.84
Total Value
$133.13K
Shares Held After
161,903
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Privia Health Group, Inc.
(PRVA)
Fargis Edward C
— EVP & General Counsel
Mar 9, 2026
Sale
Shares
4,949
Price
$22.84
Total Value
$113.04K
Shares Held After
83,711
% of Holdings
5.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Privia Health Group, Inc.
(PRVA)
Mehrotra Parth
— Director
Mar 9, 2026
Sale
Shares
18,865
Price
$22.84
Total Value
$430.88K
Shares Held After
343,795
% of Holdings
5.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Privia Health Group, Inc.
(PRVA)
Mehrotra Parth
— Director
Mar 9, 2026
Sale
Shares
1,219
Price
$23.37
Total Value
$28.49K
Shares Held After
362,660
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Privia Health Group, Inc.
(PRVA)
Mehrotra Parth
— Director
Mar 9, 2026
Sale
Shares
21,915
Price
$22.84
Total Value
$500.54K
Shares Held After
363,879
% of Holdings
5.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INTUITIVE SURGICAL INC
(ISRG)
Brosius Mark
— SVP & Chief Mfg and Supply Cha
Mar 9, 2026
Sale
Shares
645
Price
$485.01
Total Value
$312.83K
Shares Held After
1,613
% of Holdings
28.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Encompass Health Corp
(EHC)
Fay Edmund
— Sr. Vice Pres. and Treasurer
Mar 9, 2026
Sale
Shares
11,937
Price
$107.00
Total Value
$1.28M
Shares Held After
89,325
% of Holdings
11.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
DENTSPLY SIRONA Inc.
(XRAY)
Forbes James D
— Director
Mar 9, 2026
Purchase
Shares
5,000
Price
$12.48
Total Value
$62.40K
Shares Held After
10,000
% of Holdings
50.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
DENTSPLY SIRONA Inc.
(XRAY)
LUCIER GREGORY T
— Director
Mar 9, 2026
Purchase
Shares
15,000
Price
$12.45
Total Value
$186.68K
Shares Held After
65,000
% of Holdings
23.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Jazz Pharmaceuticals plc
(JAZZ)
Carr Patricia
— SVP, Chief Accounting Officer
Mar 9, 2026
Sale
Shares
1,287
Price
$182.94
Total Value
$235.44K
Shares Held After
6,512
% of Holdings
16.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BIOLIFE SOLUTIONS INC
(BLFS)
Foster Karen A.
— Chief Quality and Operations
Mar 9, 2026
Sale
Shares
500
Price
$20.00
Total Value
$10.00K
Shares Held After
113,242
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MYRIAD GENETICS INC
(MYGN)
Raha Samraat S.
— Director
Mar 9, 2026
Purchase
Shares
40,000
Price
$5.00
Total Value
$199.84K
Shares Held After
493,104
% of Holdings
8.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PROCEPT BioRobotics Corp
(PRCT)
Desai Antal Rohit
— Director
Mar 9, 2026
Purchase
Shares
1,300
Price
$25.42
Total Value
$33.04K
Shares Held After
426,262
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PROCEPT BioRobotics Corp
(PRCT)
Desai Antal Rohit
— Director
Mar 9, 2026
Purchase
Shares
53,818
Price
$24.91
Total Value
$1.34M
Shares Held After
424,962
% of Holdings
12.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PROCEPT BioRobotics Corp
(PRCT)
Desai Antal Rohit
— Director
Mar 9, 2026
Purchase
Shares
43,581
Price
$24.08
Total Value
$1.05M
Shares Held After
371,144
% of Holdings
11.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NewAmsterdam Pharma Co N.V.
(NAMS)
Kastelein Johannes Jacob Pieter
— Director
Mar 9, 2026
Sale
Shares
101,409
Price
$30.29
Total Value
$3.07M
Shares Held After
69,302
% of Holdings
59.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
Freidin Aaron
— Chief Financial Officer
Mar 9, 2026
Sale
Shares
85
Price
$46.74
Total Value
$3.97K
Shares Held After
306,475
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
Freidin Aaron
— Chief Financial Officer
Mar 9, 2026
Sale
Shares
2,407
Price
$47.93
Total Value
$115.37K
Shares Held After
306,560
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
RAGUSA ROBERT P
— Director
Mar 9, 2026
Sale
Shares
258
Price
$46.73
Total Value
$12.06K
Shares Held After
642,084
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
RAGUSA ROBERT P
— Director
Mar 9, 2026
Sale
Shares
7,203
Price
$47.93
Total Value
$345.24K
Shares Held After
642,342
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
Ofman Joshua J.
— President
Mar 9, 2026
Sale
Shares
101
Price
$46.74
Total Value
$4.72K
Shares Held After
432,881
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GRAIL, Inc.
(GRAL)
Ofman Joshua J.
— President
Mar 9, 2026
Sale
Shares
2,836
Price
$47.93
Total Value
$135.93K
Shares Held After
432,982
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CERUS CORP
(CERS)
Benjamin Richard J
— Chief Medical Officer
Mar 9, 2026
Sale
Shares
40,426
Price
$1.88
Total Value
$76.03K
Shares Held After
879,101
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
U S PHYSICAL THERAPY INC /NV
(USPH)
REEVE GRAHAM D.
— COO
Mar 6, 2026
Sale
Shares
1,807
Price
$82.25
Total Value
$148.63K
Shares Held After
1
% of Holdings
99.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Indivior Pharmaceuticals, Inc.
(INDV)
Kingsley Stuart A
— Director
Mar 6, 2026
Purchase
Shares
940
Price
$31.86
Total Value
$29.95K
Shares Held After
5,582
% of Holdings
16.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
160
Price
$484.27
Total Value
$77.48K
Shares Held After
130
% of Holdings
55.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
450
Price
$483.69
Total Value
$217.66K
Shares Held After
290
% of Holdings
60.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
200
Price
$482.74
Total Value
$96.55K
Shares Held After
740
% of Holdings
21.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
240
Price
$481.59
Total Value
$115.58K
Shares Held After
940
% of Holdings
20.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
938
Price
$480.47
Total Value
$450.68K
Shares Held After
1,180
% of Holdings
44.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
582
Price
$479.63
Total Value
$279.14K
Shares Held After
2,118
% of Holdings
21.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
1,212
Price
$478.32
Total Value
$579.72K
Shares Held After
2,700
% of Holdings
31.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
2,194
Price
$477.53
Total Value
$1.05M
Shares Held After
3,912
% of Holdings
35.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 6, 2026
Sale
Shares
880
Price
$476.37
Total Value
$419.20K
Shares Held After
6,106
% of Holdings
12.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 901–950 of 2002 transactions (page 19 of 41)
Version: v26.3.33